JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258219

Human SYNJ2 (Synaptojanin 2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SYNJ2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon3 and 68 bp deletion in exon3.

View Alternative Names

5-trisphosphate 5-phosphatase 2, INPP 5H, Inositol phosphate 5' phosphatase 2, KIAA0348, MGC44422, SJ2, SYNJ2_HUMAN, Synaptic inositol 1 4 5 trisphosphate 5 phosphatase 2, Synaptic inositol-1, Synaptojanin-2

2 Images
Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell lysate (AB258219)
  • Sanger seq

Unknown

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell lysate (AB258219)

Allele-2 : 68 bp deletion in exon3

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell lysate (AB258219)
  • Sanger seq

Unknown

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell lysate (AB258219)

Allele-1 : 14 bp deletion in exon3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon3 and 68 bp deletion in exon3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258219-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SYNJ2 knockout HeLa cell lysate", "number":"AB258219-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258219-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SYNJ2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Synaptojanin 2 also known as SYNJ2 is a protein encoded by the SYNJ2 gene. It has a molecular mass of approximately 180 kDa. Synaptojanin 2 functions as a phosphoinositide phosphatase which helps dephosphorylate phosphatidylinositol 45-bisphosphate (PIP2) to phosphatidylinositol (PI). This affects the membrane dynamics and signal transduction. The expression of synaptojanin 2 occurs in various tissues with notable abundance in the brain and testis.
Biological function summary

Synaptojanin 2 plays an important role in synaptic vesicle trafficking and endocytosis. It can function as a part of protein complexes involved in these processes. The protein is involved in rearranging the actin cytoskeleton which impacts cellular shape and movement. Its activity influences synaptic transmission efficiency by controlling the cycle of synaptic vesicles particularly in the nervous system which reflects its high expression in the brain.

Pathways

Synaptojanin 2 is closely linked to the phosphatidylinositol signaling pathway and the endocytosis pathway. These pathways are important for cellular communication and nutrient uptake. Within these pathways synaptojanin 2 interacts with proteins like dynamin a GTPase that mediates membrane fission during endocytosis. Synaptojanin 2 also functions in relation to AP-2 a clathrin adaptor complex that plays a role in vesicle formation highlighting its participation in endocytic trafficking.

Synaptojanin 2 relates to conditions such as cancer and neurodegenerative diseases. Overexpression or mutation of synaptojanin 2 associates with certain types of cancers including breast cancer potentially via disrupted signal transduction. It maintains a connection with proteins like PTEN a known tumor suppressor through its involvement in lipid signaling. In neurodegenerative diseases abnormal synaptojanin 2 function may impact neuronal health and is linked to diseases such as Alzheimer's disease. Defective phosphoinositide metabolism influences amyloid precursor protein processing implicating synaptojanin 2 in the pathology of these disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com